PR Newswire
MURFREESBORO, Tenn., Nov. 9, 2026
MURFREESBORO, Tenn., Nov. 9, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today its results for the quarter ended September 30, 2026.
CEO Comments
"SHOP and private-pay senior housing remain central to our long-term growth strategy, and we have invested in our executive management team to strengthen operating execution and improve portfolio performance," said Eric Mendelsohn, NHI's President and CEO. "Our strengthened team has developed a focused plan to address underperformance and position the portfolio for sustainable NOI growth consistent with our underwriting standards."
"We have closed more than $395 million in investments year-to-date and expect to complete significant additional investments before year-end, with ample capital available to fund our current pipeline. This activity reflects our continued confidence in private-pay senior housing and our ability to source attractive opportunities. Our focus remains on disciplined capital allocation and stronger operating execution to translate that growth into long-term value for stockholders," concluded Mr. Mendelsohn.
Third Quarter Highlights
Third Quarter Financial Results
Results for the quarter ended September 30, 2026 compared to the same period in the prior year were impacted by the following:
Portfolio Activity
Recent Pipeline Developments
Balance Sheet and Liquidity
As of September 30, 2026, the Company had $1.0 billion of consolidated net debt, including $203.0 million outstanding on its $700.0 million revolving credit facility. The Company had $46.6 million of cash and cash equivalents, $231.7 million of restricted cash and $108.3 million of deposits for future acquisitions.
The Company continues to maintain a strong financial profile with a consolidated net debt to annualized adjusted EBITDA ratio of 3.6x, which is currently well within the Company's target range of 3.5x to 4.5x. The Company is in compliance with all debt covenants as of September 30, 2026 and has investment grade credit ratings from Moody's, S&P Global and Fitch Ratings.
ATM Equity Program
Concurrently with the renewal of its shelf registration statement in March 2026, the Company entered into a new equity distribution agreement for the sale of up to $500.0 million in common stock under its ATM equity program. As of September 30, 2026, the Company had $500.0 million available under its ATM equity program.
Dividend
On November 6, 2026, the Company's board of directors declared a $0.94 per share dividend payable on January 29, 2027 to common stockholders of record as of December 31, 2026.
2026 Full-Year Guidance
The Company's 2026 full-year guidance range, including information on the underlying assumptions and timing of certain transactions, is set forth below (in millions, except per share amounts):
2026 Guidance Range | |||
Low | High | ||
Net income attributable to common stockholders | $ 687.0 | $ 687.6 | |
Adjustments to NAREIT FFO: | |||
Depreciation, net1 | 97.0 | 97.2 | |
Gains on dispositions and impairments of real estate properties | (556.5) | (556.7) | |
Participating securities | 1.0 | 1.1 | |
NAREIT FFO attributable to common stockholders | 228.5 | 229.2 | |
Adjustments to Normalized FFO attributable to common stockholders: | |||
Other | — | — | |
Normalized FFO attributable to common stockholders | 228.5 | 229.2 | |
Adjustments to FAD attributable to common stockholders: | |||
Straight-line rent revenue and lease incentives amortization, net1 | 0.4 | 0.5 | |
Equity method investment adjustments | (1.8) | (1.7) | |
Equity method investment non-refundable fees received | 1.4 | 1.5 | |
Non-cash share-based compensation expense | 7.8 | 7.7 | |
SHOP1 and equity method investment recurring capital expenditures | (6.7) | (6.6) | |
Other1, 2 | 7.0 | 7.1 | |
FAD attributable to common stockholders | $ 236.6 | $ 237.7 | |
Weighted average common shares outstanding - diluted | 48.8 | 48.8 | |
NAREIT FFO per diluted share | $ 4.68 | $ 4.70 | |
Normalized FFO per diluted share | $ 4.68 | $ 4.70 | |
1 Net of amounts attributable to noncontrolling interests |
2 Includes credit loss reserves, non-real estate depreciation, net, amortizations associated with debt facilities and participating securities. |
The Company's 2026 full-year guidance includes the following assumptions:
In addition to the assumptions listed above, the Company's guidance range is based on several other assumptions, many of which are outside the Company's control and all of which are subject to change. The Company's guidance range may change if actual results vary from these assumptions.
Investor Conference Call and Webcast
The Company will host a conference call on Tuesday, November 10, 2026, at 10:00 a.m. ET, to discuss its third quarter 2026 results. The number to call for this interactive teleconference is (888) 506-0062, with the confirmation number 260192. The live broadcast of the Company's third quarter conference call will be available online at www.nhireit.com. The online replay will follow shortly after the call and remain available for one year.
About National Health Investors, Inc.
National Health Investors, Inc. (NYSE: NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). The Company owns, leases, operates and finances the development of high-quality real estate properties throughout the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. For more information, visit www.nhireit.com.
Reconciliations of FFO, Normalized FFO and Normalized FAD (unaudited and $ in thousands, except per share amounts)
| |||||||
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income attributable to common stockholders | $ 562,680 | $ 32,812 | $ 658,280 | $ 103,863 | |||
Real estate depreciation and amortization | 24,760 | 19,662 | 72,175 | 57,903 | |||
Real estate depreciation attributable to noncontrolling interests | (405) | (400) | (1,211) | (1,227) | |||
Impairments of real estate properties | 9,866 | — | 9,866 | — | |||
Gains on dispositions of real estate properties | (542,704) | (113) | (567,283) | (337) | |||
Adjustments attributable to holders of participating securities | 763 | — | 739 | — | |||
NAREIT FFO attributable to common stockholders | 54,960 | 51,961 | 172,566 | 160,202 | |||
Non-cash write-offs of straight-line rents receivable | — | 12,141 | — | 12,350 | |||
Non-cash rental income related to operations transfers upon | |||||||
early lease terminations | — | (1,375) | — | (1,375) | |||
Proxy contest and related expenses | — | — | — | 1,572 | |||
Normalized FFO attributable to common stockholders | 54,960 | 62,727 | 172,566 | 172,749 | |||
Non-cash rent revenue adjustments, net | 316 | (616) | 258 | (2,108) | |||
Non-real estate depreciation and amortization, net | 924 | 487 | 2,597 | 1,202 | |||
Amortization of debt issuance costs and discounts | 807 | 658 | 2,515 | 2,572 | |||
Adjustments attributable to equity method investment, net | (824) | (273) | (1,547) | (2,860) | |||
Equity method investment non-refundable fees received | 445 | 929 | 1,072 | 1,862 | |||
Recurring capital expenditures, net | (2,230) | (668) | (4,184) | (1,601) | |||
Credit loss benefit | (149) | (1,979) | (258) | (3,386) | |||
Share-based compensation expense | 1,463 | 983 | 6,063 | 4,612 | |||
Transaction costs | 1,148 | — | 1,148 | 1,164 | |||
Deferred income tax expense | 224 | — | 956 | — | |||
Adjustments attributable to holders of participating securities | (6) | — | (17) | — | |||
Normalized FAD attributable to common stockholders | $ 57,078 | $ 62,248 | $ 181,169 | $ 174,206 | |||
Basic: | |||||||
Weighted average common shares outstanding | 49,037,240 | 47,433,336 | 48,599,033 | 46,615,262 | |||
NAREIT FFO attributable to common stockholders per share | $ 1.12 | $ 1.10 | $ 3.55 | $ 3.44 | |||
Normalized FFO attributable to common stockholders per share | $ 1.12 | $ 1.32 | $ 3.55 | $ 3.71 | |||
Diluted: | |||||||
Weighted average common shares outstanding | 49,041,952 | 47,623,623 | 48,696,008 | 46,774,872 | |||
NAREIT FFO attributable to common stockholders per share | $ 1.12 | $ 1.09 | $ 3.54 | $ 3.42 | |||
Normalized FFO attributable to common stockholders per share | $ 1.12 | $ 1.32 | $ 3.54 | $ 3.69 | |||
See the accompanying notes to the reconciliations of FFO, Normalized FFO, Normalized FAD and NOI. | |||||||
The following table reconciles net income, the most directly comparable generally accepted accounting principles ("GAAP") financial measure, to NOI (unaudited and $ in thousands):
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income | $ 563,214 | $ 32,478 | $ 658,323 | $ 102,984 | |||
Depreciation and amortization | 25,763 | 20,216 | 75,002 | 59,291 | |||
Interest expense | 12,521 | 13,766 | 43,375 | 43,104 | |||
Legal expense | 1,050 | 134 | 1,800 | 2,655 | |||
Franchise, excise and other taxes | 243 | 244 | 671 | 756 | |||
General and administrative expenses | 8,005 | 6,311 | 24,679 | 19,265 | |||
Proxy contest and related expenses | — | — | — | 1,572 | |||
Loan and realty losses (gains), net | 9,717 | (1,979) | 9,608 | (3,386) | |||
Gains on dispositions of real estate properties | (542,704) | (113) | (567,283) | (337) | |||
Other non-operating income | (2,854) | — | (2,975) | — | |||
Income tax expense | 279 | — | 1,011 | — | |||
Gain from equity method investment | (688) | (73) | (688) | (2,012) | |||
NOI | $ 74,546 | $ 70,984 | $ 243,523 | $ 223,892 | |||
The following table provides a summary of the Company's NOI by segment (unaudited and $ in thousands):
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Real Estate Investments segment | $ 63,028 | $ 66,060 | $ 212,092 | $ 212,061 | |||
SHOP segment | 11,518 | 4,924 | 31,431 | 11,831 | |||
Total NOI | $ 74,546 | $ 70,984 | $ 243,523 | $ 223,892 | |||
The following table provides additional information on the Company's SHOP segment NOI (unaudited and $ in thousands):
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Same Store properties1 | $ 3,539 | $ 2,962 | $ 10,133 | $ 9,869 | |||
Acquisitions | 5,471 | — | 13,172 | — | |||
Transitioned properties | 2,508 | 1,962 | 8,126 | 1,962 | |||
Total SHOP segment NOI | $ 11,518 | $ 4,924 | $ 31,431 | $ 11,831 | |||
1 Same Store is defined in the accompanying notes below.
See the accompanying notes to the reconciliations of FFO, Normalized FFO, Normalized FAD and NOI. | |||||||
Notes to the Reconciliations of FFO, Normalized FFO, Normalized FAD, NOI and Same Store
The supplemental performance measures described below may not be comparable to similarly titled measures used by other REITs. Consequently, funds from operations ("FFO"), Normalized FFO, Normalized FAD, NOI and Same Store, as presented herein, may not provide a meaningful measure of the Company's performance as compared to that of other REITs. Since other REITs may not use a similar definition of these performance measures, caution should be exercised when comparing FFO, Normalized FFO, Normalized FAD, NOI and Same Store, as presented herein, to that of other REITs. These performance measures do not represent cash generated from operating activities in accordance with GAAP as they exclude the changes in operating assets and liabilities, and therefore should not be considered an alternative to net income as an indication of performance or as an alternative to net cash flows from operating activities, as determined in accordance with GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs. We calculate basic and diluted weighted average shares outstanding on a similar basis to GAAP when calculating our non-GAAP financial measures on a per share basis.
Funds From Operations - FFO
FFO and Normalized FFO are important supplemental performance measures for REITs. These performance measures are useful in that the historical cost accounting convention under GAAP requires real estate assets, other than land, to be depreciated over their estimated useful lives implying that the realizable values of real estate assets diminish predictably over time. Since real estate asset values typically rise and fall with market conditions, presentations of operating results of REITs using the historical cost accounting convention could be considered less informative to investors and should be supplemented with a measure such as FFO. FFO was designed by the REIT industry as a supplemental performance measure to address this issue.
The Company defines FFO, or NAREIT FFO, as net income attributable to common stockholders excluding gains on dispositions of real estate properties, impairments of real estate properties and real estate depreciation and amortization expense. These exclusions are adjusted to remove the impact of amounts that are attributable to noncontrolling interests and holders of participating securities. The Company's computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or have a different interpretation of the current NAREIT definition from that of the Company, and therefore caution should be exercised when comparing the Company's FFO to that of other REITs.
Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current periods to similar prior periods. These adjustments may include, but are not limited to, impairments of non-real estate assets, gains or losses on non-real estate assets and liabilities and recoveries of previous write-downs on mortgage and other notes receivable.
Funds Available for Distribution - FAD
Normalized FAD is also an important supplemental performance measure for REITs. It is a useful measure of liquidity and serves as an indicator of the Company's ability to distribute dividends to its stockholders each period. GAAP requires a lessor to recognize contractual lease payments as income on a straight-line basis over the expected term of the lease. This straight-line rent adjustment has the effect of reporting rental income that is significantly more or less than the contractual cash flows received pursuant to the terms of the lease agreements. GAAP also requires any discount or premium related to indebtedness and debt issuance costs to be amortized as non-cash adjustments to earnings. Normalized FAD includes adjustments for these types of non-cash items of a recurring nature typical to REITs and is further adjusted to reflect the cash outflows for recurring capital expenditures. Certain other costs that fluctuate that are not related to the recurring business are also excluded from Normalized FAD.
The Company defines Normalized FAD as Normalized FFO excluding straight-line rent revenue adjustments, amortization of lease incentives, non-real estate depreciation and amortization expense, amortization of debt issuance costs and discounts and certain transaction costs. The Company also adjusts Normalized FAD for the net change in its credit loss reserves, share-based compensation expense, SHOP capital expenditures, deferred income tax expense, as well as certain non-cash items related to the Company's equity method investment, such as straight-line lease expense and amortization of purchase accounting adjustments. The Company removes the impact of the above adjustments that are attributable to noncontrolling interests and holders of participating securities. Normalized FAD for each of the quarter and nine months ended September 30, 2026 and for the nine months ended September 30, 2025 included adjustments for transaction costs which related to transactions in the SHOP segment that the Company stopped pursuing during these periods.
NOI
NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate assets. The Company defines NOI as total revenues, less tenant reimbursements of property operating expenses and senior housing operating expenses. The Company believes NOI provides relevant and useful information to investors as it measures the operating performance of real estate assets at the property level on an unleveraged basis. The Company also uses NOI in making decisions about resource allocations to its operating segments.
Same Store
The Company defines Same Store as real estate properties owned, consolidated and operational for the full period in both comparative periods and that are not otherwise excluded; provided, however, that the Company may include selected properties that otherwise meet the Same Store criteria if they are included in substantially all of, but not a full, period for one or both of the comparative periods, and in management's judgment such inclusion provides a more meaningful presentation of the Company's segment performance.
Newly acquired properties, recently developed or redeveloped properties and properties undergoing an operator transition will be included in Same Store after five full quarters from the date of acquisition, transition or being placed into service. SHOP properties and properties with triple-net leases that have undergone operator or business model transitions will be included in Same Store once operating under consistent operating structures for the full period in both periods presented.
Properties are excluded from Same Store if they are: (i) sold, classified as assets held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by significant disruptive events such as flood or fire; (iii) those properties that are currently undergoing a significant disruptive redevelopment; or (iv) those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period.
Condensed Consolidated Statements of Income (unaudited and $ in thousands, except per share amounts)
| |||||||
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Revenues: | |||||||
Rental income | $ 60,652 | $ 62,178 | $ 205,192 | $ 201,314 | |||
Resident fees and services | 47,706 | 21,177 | 129,545 | 49,333 | |||
Interest and other income | 5,125 | 6,492 | 15,195 | 19,158 | |||
Total revenues | 113,483 | 89,847 | 349,932 | 269,805 | |||
Expenses: | |||||||
Depreciation and amortization | 25,763 | 20,216 | 75,002 | 59,291 | |||
Interest expense | 12,521 | 13,766 | 43,375 | 43,104 | |||
Senior housing operating expenses | 36,188 | 16,253 | 98,114 | 37,502 | |||
Legal expense | 1,050 | 134 | 1,800 | 2,655 | |||
Franchise, excise and other taxes | 243 | 244 | 671 | 756 | |||
General and administrative expenses | 8,005 | 6,311 | 24,679 | 19,265 | |||
Proxy contest and related expenses | — | — | — | 1,572 | |||
Taxes and insurance on leased properties | 2,749 | 2,610 | 8,295 | 8,411 | |||
Loan and realty losses (gains), net | 9,717 | (1,979) | 9,608 | (3,386) | |||
Total expenses | 96,236 | 57,555 | 261,544 | 169,170 | |||
Gains on dispositions of real estate properties | 542,704 | 113 | 567,283 | 337 | |||
Other non-operating income | 2,854 | — | 2,975 | — | |||
Income before income taxes and equity | |||||||
method investment | 562,805 | 32,405 | 658,646 | 100,972 | |||
Income tax expense | (279) | — | (1,011) | — | |||
Gain from equity method investment | 688 | 73 | 688 | 2,012 | |||
Net income | 563,214 | 32,478 | 658,323 | 102,984 | |||
Add: Net loss attributable to noncontrolling interests | 311 | 384 | 975 | 1,030 | |||
Net income attributable to stockholders | 563,525 | 32,862 | 659,298 | 104,014 | |||
Less: Net income allocated to participating securities | (845) | (50) | (1,018) | (151) | |||
Net income attributable to common stockholders | $ 562,680 | $ 32,812 | $ 658,280 | $ 103,863 | |||
Weighted average common shares outstanding: | |||||||
Basic | 49,037,240 | 47,433,336 | 48,599,033 | 46,615,262 | |||
Diluted | 49,041,952 | 47,623,623 | 48,696,008 | 46,774,872 | |||
Earnings per share: | |||||||
Basic | $ 11.47 | $ 0.69 | $ 13.55 | $ 2.23 | |||
Diluted | $ 11.47 | $ 0.69 | $ 13.52 | $ 2.22 | |||
Selected Condensed Consolidated Balance Sheet Data ($ in thousands)
| |||
September 30, | December 31, | ||
2026 | 2025 | ||
(unaudited) | |||
Real estate properties, net | $ 2,534,822 | $ 2,472,272 | |
Mortgage and other notes receivable, net | 209,445 | 203,296 | |
Cash and cash equivalents | 46,559 | 19,624 | |
Restricted cash | 231,738 | — | |
Deposits on real estate acquisitions | 108,309 | — | |
Straight-line rents receivable | 74,557 | 78,891 | |
Assets held for sale, net | 3,050 | 3,562 | |
Other assets, net | 34,975 | 19,242 | |
Debt, net | 1,040,329 | 1,163,814 | |
National Health Investors, Inc. stockholders' equity | 2,089,956 | 1,521,543 | |
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's expected future financial positions, results of operations, cash flows, funds from operations, dividend and dividend plans, financing opportunities and plans, capital market transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, acquisition integration, growth opportunities, expected rental income, continued qualification as a REIT, plans and objectives of management for future operations, continued performance improvements, ability to service and refinance debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as "may", "will", "should", "believes", "anticipates", "expects", "intends", "estimates", "plans", "projects", "target", "likely" and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include those risks and uncertainties which are described under the heading "Risk Factors" in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any forward-looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by the Company in its periodic reports filed with the Securities and Exchange Commission ("SEC"), including the risk factors and other information in the above referenced Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Copies of these filings are available at no cost on the SEC's website at https://www.sec.gov or on the Company's website at www.nhireit.com.
Contact: Todd M. Siefert, Chief Financial Officer
Phone: (615) 890-9100
View original content to download multimedia:https://www.prnewswire.com/news-releases/nhi-announces-third-quarter-2026-results-302933728.html
SOURCE National Health Investors, Inc.
